WHITE PAPER: AF Treatments in Regenerative Medicine

Posted at 1st October 2017

Over the past few years, the use of amniotic fluid (AF) tissues has increased dramatically. As more practitioners discover the benefits of AF treatment and applications continue to proliferate, it’s important to explore the science that supports AF.

A new white paper offers and in-depth review, along with several eye-opening details. Key points:

  • Amniotic fluid contains many complex bioactive and signaling components that are critical to its therapeutic mechanism of action.
  • Studies indicate that AF shows promise in various therapeutic and clinical applications.
  • An AF allograft improved pain and functionality and had a lower occurrence of adverse effects compared to other injections in osteoarthritic knees.
  • Cryopreservation complicates cold-chain logistics and, once thawed, cryopreserved products may only retain integrity for a small amount of time before the components that make them effective begin to degrade.

Learn more about Ascent, the AF injectable allograft, or read the entire white paper.

 

DOWNLOAD WHITE PAPER